Mycosynthesis of silver nanoparticles using lingzhi or reishi medicinal mushroom, ganoderma lucidum (W. Curt.:Fr.) P. karst. and their role as antimicrobials and antibiotic activity enhancers

International Journal of Medicinal Mushrooms

Volumn 13, Issue 5, 2011, Pages 483-491

  Karwa, Alka ^a   Gaikwad, Swapnil ^a   Rai, Mahendra ^a  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Antibacterial activity; Ganoderma lucidum; Medicinal mushrooms; Mycoenhancing; Mycosynthesis; Silver nanoparticles

Indexed keywords

GANODERMA LUCIDUM EXTRACT; SILVER NANOPARTICLE; SILVER NITRATE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SYNTHESIS; ESCHERICHIA COLI; GANODERMA LUCIDUM; INFRARED SPECTROSCOPY; MYCELIUM; NONHUMAN; PARTICLE SIZE; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET SPECTROSCOPY;

EID: 82255167127     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v13.i5.80     Document Type: Article

References (50)

1. Mann S. Biomimetic materials chemistry. S. Mann (ed.), New York: VCH; 1996.
2. Herrera M, Carrion P, Baca P, Liebana J, Castillo A. In vitro antibacterial activity of glass ionomer cements. Microbios. 2001;104:141-8.
3. Bosseti M, Masse A, Tobin E, Cannas M. Silver coated materials for external fixation device: in vitro biocompatibility and genotoxicity. Biomaterials. 2002;23 (3):887-892.
4. Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol. 2003;69:4278-81.
5. Alivisatos AP. Perspectives on the physical chemistry of semiconductor nanocrystals. J Phys Chem. 1996;100:13226-9.
6. Jin R, Cao Y, Mirkin CA, Kelly KL, Schatz GC, Zheng JG. Photoinduced conversion of silver nanospheres to nanoprisms. Science. 2001;294(5548):1901-3.
7. Aizpurua J, Hanarp P, Sutherland DS, Kall M, Bryant GW, de Abajo FJG. Optical properties of gold nanorings. Phys Rev Lett. 2003;90:57401.
8. Song JY, Kwon EY, Kim BS. Biological synthesis of platinum nanoparticles using Diopyros kaki leaf extract. Bioprocess Biosyst Eng. 2010;33(1):159-64.
9. Mukherjee P, Ahmad A, Mandal D, Senapati S, Sainkar SR, Khan MI, Ramani R, Parischa R, Ajaykumar PV, Alam M, Sastry M, Kumar R. Extracellular biosynthesis of biometallic Au-Ag alloy nanoparticles. Angew Chem Int Ed. 2001a; 40: 3585-88.
10. Mukherjee P, Ahmad A, Mandal D, Senapati S, Sainkar SR, Khan MI, Parischa R, Ajayakumar PV, Alam M, Kumar R, Sastry M. Extracellular biosynthesis of biometalliuc Au-Ag alloy nanoparticles. Nano Lett. 2001b; 1: 515-19.
11. Konish Y, Deshmukh N, Tsukiyama T, Saitoh N. Microbial preparation of gold nanoparticles by anaerobic bacterium. Trans Mater Res Soc Jpn. 2004; 29: 2341.
12. Bhainsa KC, Disouza SF. Extracellular synthesis of silver nanoparticles using the fungus Aspergillus fumigatus. Colloids Surf B Biointerfaces. 2006; 47: 160-64.
13. Vigneshwaran N, Ashtapure NM, Varasarajan PV, Nachane RP, Paralikar KM, and Balasubramanian RH. Biological synthesis of silver nanoparticles using the fungus Aspergillus flavus. Longmuir. 2007; 23: 7113-17.
14. Gade AK, Bonde P, Ingle AP, Marcato PD, Duran N, Rai MK. Exploitation of Aspergillus niger for synthesis of silver nanoparticles, J Biobased Mater Bioenergy. 2008;2:243-47.
15. Ingle A, Gade A, Pierrat S, Sonnichsen C, Rai M. Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci. 2008;4:141-44.
16. Gajbhiye M, Kesharwani J, Ingle A, Gade A, Rai M. Fungus mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomedicine. 2009;5:382-86.
17. Lamb AE, Anderson WN, Haverkamp RG. The induced accumulation of gold in the plants Brassica juncea, Berkheya coddii and Brassica chicory. Chem New Zeal. 2001;9:34-36.
18. Shankar SS, Ahmad A, Rai A, Sastry M. Rapid synthesis of Au, Ag and bimetallic Au core Ag shell nanoparticles by using neem (Azadirachta indica) leaf broth. J Colloid Interface Sci. 2004;275:496-502.
19. Chandran SP, Chaudhary M, Pasricha R, Ahmad A, Sastry M. Synthesis of goldnanotriangles and silver nanotriangles using Aloe vera plant extract. Biotechnol Prog. 2006;22:577-79.
20. Huang J, Chen C, He N, Hong J, Lu Y, Qingbiao L, Shao W, Sun D, Wang XH, Wang Y, Yiang X. Biosynthesis of silver and gold nanoparticles by novel sun dried Cinnamomum camphora leaf. Nanotechnology. 2007;18:105-6.
21. Li S, Shen Y, Xie A, Yu X, Qiu L, Zhang L, Zhang Q. Green synthesis of silver nanoparticles using Capsicum annuum L. extract. Green Chem. 2007;9:825-58.
22. Kumar V, Yadav SK. Plant-mediated synthesis of silver and gold nanoparticles and their applications. J Chem Technol Biotechnol. 2009;84:151-57.
23. Sanghi R, Verma P. Biomimetic synthesis and characterization of protein capped silver nanoparticles. Bioresour Technol. 2009;100:501-4.
24. Gade A, Rai MK, Karwa A, Bonde P, Ingle A. Extracellular biosynthesis of silver nanoparticles by Pleurotus species. Intl J Med Mushr. 2007;9(3-4):298-99.
25. Duran N, Marcarto PD, De Souza GIH, Alves OL, Esposito E. Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J Biomed Nanotechnol. 2007;3:203-8.
26. Duran N, Marcato DP, Alves LO, Desouza HG, Esposito E. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J Nanobiotechnol. 2005;3:8.
27. Bandow JE, Brotz H, Leichert LIO, Labischinski H, Hecker M. Proteomic approach to understanding antibiotic action. Antimicrob Agents Chemother. 2003;47:948-55.
28. Wright GD. Bacterial resistance to antibiotics: Enzymatic degradation and modifications. Adv Drug Delivery Rev. 2005;57:1451-70.
29. Ali MD, Sasikala M, Gunasekaran M, Thajuddin N. Biosynthesis and characterization of silver nanoparticles using marine cyanobacterium Oscillatoria willeint DM01. J Nanomat Biostruct. 2009;6(2):385-90.
30. Stoimenov PK, Klinger RL, Marchinand GL, Khabude KJ. Metal oxide nanoparticles as bactericidal agents. Longmuir. 2002;18:6679-86.
31. Tokumaru T, Shimizu Y, Fox CL. Antiviral activities of silver sulfadiazine and ocular infection. Res common chem. Pathol Pharmocol. 1984; 8:151-158.
32. Oloffs A, Crosse-siestrup C, Bisson S, Rinck M, Rudolvh R, Gross U. Biocompatibility of silver coated polyurethane catheters and silver coated dacron material. Biomaterial. 1994;15:753-58.
33. Oka M, Tonioka T, Tomita K, Nishino A, Ueda S. Inactivation of enveloped viruses by a silver thiosulfate complex. Metal Based Drugs. 1994;1:511.
34. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JBV, Ramirez JT, Yacaman MJ. The bacterial effect of silver nanoparticles. Nanotechnology. 2005; 16:2346-53.
35. Elechiguerra C, Burt JC, Morones JR, Camacho A, Bragudo Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;3:6.
36. Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B. 2003;28:313-18.
37. Shankar S, Ahmad A, Sastry M. Geranium leaf assisted biosynthesis of silver nanoparticles. Biotechnol Prog. 2003;19:1627-31.
38. Sadowski Z, Maliszewska I, Polowczyk I, Kozlecki T, Grochowalska B. Biosynthesis of colloidal-silver particles using microorganisms. Polish J Chem. 2008;82:377-82.
39. Sadowski Z, Maliszewska HI, Grochowalska B, Polowczyk I, Kozlecki T. Synthesis of silver nanoparticles using microorganisms. Mater Sci Poland. 2008;26(2):419-24.
40. Kowshik M, Ashtaputre S, Kharrazi S, Vogel W, Urban J, Kulkarni SK, Paknikar KM. Extracellular synthesis of silver nanoparticles by a silver tolerant yeast strain MKY3. Nanotechnology. 2003;14:95-100.
41. Nithya R, Raghunathan R. Synthesis of silver nanoparticle using Pleurotus sajor caju and its antimicrobial study. Digest J Nanomat Biostruct. 2009;4(4):623-29.
42. Montes-Burgos I, Walczyk D, Hole P, Smith J, Lynch I, Dawson K. Characterisation of nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res. 2010;12:47-53.
43. Bonde SR, Rathod DP, Ingle AP, Gade AK, Rai MK. Murraya koenigii mediated synthesis of silver nanoparticles and its activity against three human pathogenic bacteria. J Expt Nanosci. 2011. (In Press).
44. Baker RA, Tatum JH. Novel anthraquinones from stationary cultures of Fusarium oxysporum. J Ferment Bioeng. 1998;85:359-61.
45. Philip D. Biosynthesis of Au, Ag and Au-Ag nanoparticles using edible mushroom extract. Spectrochemia Acta Part A. 2009;73:374-81.
46. Karwa A, Rai M. Mycoenhancing the potential of synthetic antibiotics using wild mushrooms; first report. Proc Fifth Int Med Mushr Conf Nantong. 5-8 Sep 2009; 167-72.
47. Karwa A, Rai MK. Tapping into the edible fungi biodiversity of Central India. Biodiversitas. 2010;11(2):97-101.
48. Birla SS, Tiwari VV, Gade AK, Ingle AP, Yadav AP, Rai MK. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol. 2009;48:173-79.
49. Singh M, Singh S, Prasad S, Gambhir IS. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Digest J Nanomater Biostruct. 2007;3(3):115-22.
50. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27:76-83.